- Tytuł:
- Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32‐week real‐world experience during the COVID‐19 pandemic.
- Autorzy:
- Temat:
-
ATOPIC dermatitis
DUPILUMAB
COVID-19 pandemic
TEENAGERS - Źródło:
- Clinical & Experimental Dermatology; Jan2022, Vol. 47 Issue 1, p165-167, 3p, 2 Charts
Czasopismo naukowe